Cargando…

Sustainable Stabilizer-Free Nanoparticle Formulations of Valsartan Using Eudragit(®) RLPO

The bioavailability of the antihypertensive drug valsartan can be enhanced by various microencapsulation methods. In the present investigation, valsartan-loaded polymeric nanoparticles were manufactured from Eudragit(®) RLPO using an emulsion–solvent evaporation method. Polyvinyl alcohol (PVA) was f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hajba-Horváth, Eszter, Fodor-Kardos, Andrea, Shah, Nishant, Wacker, Matthias G., Feczkó, Tivadar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657980/ https://www.ncbi.nlm.nih.gov/pubmed/34884873 http://dx.doi.org/10.3390/ijms222313069

Ejemplares similares

Preparation and in vitro characterization of valsartan-loaded ethyl cellulose and poly(methyl methacrylate) nanoparticles
por: Hajba-Horváth, Eszter, et al.
Publicado: (2020)

Sustained in vitro interferon-beta release and in vivo toxicity of PLGA and PEG-PLGA nanoparticles
por: Fodor-Kardos, Andrea, et al.
Publicado: (2020)

Design, Development, and Optimization of Sterculia Gum-Based Tablet Coated with Chitosan/Eudragit RLPO Mixed Blend Polymers for Possible Colonic Drug Delivery
por: Nath, Bipul, et al.
Publicado: (2013)

Topical Formulation of Nano Spray-Dried Levocetirizine Dihydrochloride against Allergic Edema
por: Mirankó, Mirella, et al.
Publicado: (2022)

Poly(3-Hydroxybutyrate)-Based Nanoparticles for Sorafenib and Doxorubicin Anticancer Drug Delivery
por: Babos, György, et al.
Publicado: (2020)

Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment
por: Tang, Jingling, et al.
Publicado: (2011)

Halochromic Behavior and Anticancer Effect of New Synthetic Anthocyanidins Complexed with β-Cyclodextrin Derivatives
por: Păușescu, Iulia, et al.
Publicado: (2022)

Formulation and in vitro Evaluation of Alfuzosin Extended Release Tablets Using Directly Compressible Eudragit
por: Roni, M. A., et al.
Publicado: (2009)

Formulation, Characterization, and Evaluation of Eudragit-Coated Saxagliptin Nanoparticles Using 3 Factorial Design Modules
por: Alhamhoom, Yahya, et al.
Publicado: (2022)

Design, Formulation, and Characterization of Valsartan Nanoethosomes for Improving Their Bioavailability
por: Nasr, Ali M., et al.
Publicado: (2022)

The effect of pectin on swelling and permeability characteristics of free films containing Eudragit RL and/or RS as a coating formulation aimed for colonic drug delivery
por: Akhgari, A., et al.
Publicado: (2010)

Development of Lyophilised Eudragit(®) Retard Nanoparticles for the Sustained Release of Clozapine via Intranasal Administration
por: Lombardo, Rosamaria, et al.
Publicado: (2023)

Development and Characterization of Eudragit(®)-Based Electrospun Nanofibrous Mats and Their Formulation into Nanofiber Tablets for the Modified Release of Furosemide
por: Vlachou, Marilena, et al.
Publicado: (2019)

Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine
por: Salatin, Sara, et al.
Publicado: (2020)

Formulation and optimisation of lamivudine‐loaded Eudragit(®) S 100 polymer‐coated pectin microspheres for colon‐specific delivery
por: Vilas, Satheesh, et al.
Publicado: (2021)

The Effect of Thermal-Treating on Drug Release from Sustained Release Alginate-Eudragit RS Matrices
por: Kaffash, Ehsan, et al.
Publicado: (2021)

Preparation and Evaluation of Valsartan Liquid Filling Formulations for Soft Gels
por: Sanaboina, Jyothi, et al.
Publicado: (2013)

Theranostic Sorafenib-Loaded Polymeric Nanocarriers Manufactured by Enhanced Gadolinium Conjugation Techniques
por: Feczkó, Tivadar, et al.
Publicado: (2019)

Formulation and in vitro evaluation of Eudragit S-100 coated naproxen matrix tablets for colon-targeted drug delivery system
por: Mehta, Rohit, et al.
Publicado: (2013)

Formulation, characterization and evaluation of the effect of polymer concentration on the release behavior of insulin-loaded Eudragit(®)-entrapped mucoadhesive microspheres
por: Kenechukwu, Franklin C., et al.
Publicado: (2016)

In vitro-in vivo evaluation of xanthan gum and eudragit inter polyelectrolyte complex based sustained release tablets
por: Deb, Tamal Krishna, et al.
Publicado: (2015)

Immobilization of Metronidazole on Mesoporous Silica Materials
por: Szentmihályi, Klára, et al.
Publicado: (2022)

Design, Preparation, and Evaluation of Enteric Coating Formulation of HPMC and Eudragit L100 on Carboxylated Agarose Hydrogel by Using Drug Tartrazine
por: Khan, Muhammad Junaid, et al.
Publicado: (2022)

Eudragit(®) Microparticles for the Release of Budesonide: A Comparative Study
por: Cortesi, Rita, et al.
Publicado: (2012)

Endovascular Embolization of Brain Arteriovenous Malformations with Eudragit-E
por: TAMURA, Goichiro, et al.
Publicado: (2015)

Eudragit Films as Carriers of Lipoic Acid for Transcorneal Permeability
por: Bierbrauer, Karina L., et al.
Publicado: (2023)

Dual Drug Delivery of Sorafenib and Doxorubicin from PLGA and PEG-PLGA Polymeric Nanoparticles
por: Babos, György, et al.
Publicado: (2018)

Formulation and Bioequivalence of Two Valsartan Tablets After a Single Oral Administration
por: Zaid, Abdel Naser, et al.
Publicado: (2011)

Uptake of Eudragit Retard L (Eudragit(®) RL) Nanoparticles by Human THP-1 Cell Line and Its Effects on Hematology and Erythrocyte Damage in Rats
por: Abdel-Wahhab, Mosaad A., et al.
Publicado: (2014)

Preparation, Evaluation and Bioavailability Studies of Eudragit Coated PLGA Nanoparticles for Sustained Release of Eluxadoline for the Treatment of Irritable Bowel Syndrome
por: Anwer, Md. K., et al.
Publicado: (2017)

Development and Characterization of Eudragit-RL-100-Based Aceclofenac Sustained-Release Matrix Pellets Prepared via Extrusion/Spheronization
por: Ibrahim, Mohamed Abbas, et al.
Publicado: (2021)

NICLOSAMIDE-EXFOLIATED ANIONIC CLAY NANOHYBRID REPURPOSED AS AN ANTIVIRAL DRUG FOR TACKLING COVID-19; ORAL FORMULATION WITH TWEEN 60/EUDRAGIT S100
por: Rejinold, N. Sanoj, et al.
Publicado: (2021)

Eluxadoline-Loaded Eudragit Nanoparticles for Irritable Bowel Syndrome with Diarrhea: Formulation, Optimization Using Box–Behnken Design, and Anti-Diarrheal Activity
por: Anwer, Md. Khalid, et al.
Publicado: (2023)

Formation and Investigation of Electrospun Eudragit E100/Oregano Mats
por: Baranauskaite, Juste, et al.
Publicado: (2019)

Ketoprofen-loaded Eudragit electrospun nanofibers for the treatment of oral mucositis
por: Reda, Rana Ihab, et al.
Publicado: (2017)

Synthesis of nano-α mangostin based on chitosan and Eudragit S 100
por: Herdiana, Yedi, et al.
Publicado: (2020)

Nanoformulated Eudragit lopinavir and preliminary release of its loaded suppositories
por: Katata-Seru, Lebogang, et al.
Publicado: (2020)

A Systematic Overview of Eudragit(®) Based Copolymer for Smart Healthcare
por: Nikam, Aniket, et al.
Publicado: (2023)

Formulation Development and Evaluation of Drug Release Kinetics from Colon-Targeted Ibuprofen Tablets Based on Eudragit RL 100-Chitosan Interpolyelectrolyte Complexes
por: Ofokansi, Kenneth Chibuzor, et al.
Publicado: (2013)

Data on statistical experimental design to formulate amphotericin B-loaded Eudragit RL100 nanoparticles coated with hyaluronic acid for the treatment of vulvovaginal candidiasis
por: Melo, Carolina M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8p526jitpdltega01h7bbkbae8